Small Cap News Movers for 11/2/09

Human Genome Sciences, Inc. (NASDAQ: HGSI) and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA(TM) (belimumab) met the primary endpoint in BLISS-76, the second of two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE). BLISS-76 study results through 52 weeks showed that belimumab 10 mg/kg plus standard of care achieved a statistically significant improvement in patient response rate as measured by the SLE Responder Index at Week 52, compared with placebo plus standard of care. The stock closed at $25.28, up 35.28%, on 40,710,649 traded shares.

Crimson Exploration Inc. (OTCBB: CXPO) today announced that its Kardell Gas Unit #1H well in San Augustine County, Texas, in which the Company owns a 52% working interest, was successfully completed in the Haynesville Shale formation. The Kardell #1H was drilled to a total measured depth of 18,350 feet with a total lateral length of approximately 4,500 feet and 12 stages of fracture treatment. The Kardell #1H experienced one of the highest reported 24-hour initial potential rates for a Haynesville Shale well (East Texas and North Louisiana) at 30.7 million cubic feet of natural gas per day. The stock closed at $7.95, up 39.72%, on 147,520 traded shares.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future.